Company Monitoring Page for Dendreon

latest headlines for company on cafepharma

Dendreon ups its Provenge marketing game with help from NBA all-star Grant Hill
Fierce Pharma
Tue, 12/7/21 - 11:41 pm
Tags:
Dendreon, Provenge, pharma marketing, prostate cancer, celebrity endorsements
Dendreon makes leap to become cell therapy CMO
Biopharma Reporter
Fri, 06/25/21 - 11:04 am
Tags:
Dendreon, cell therapy, CMOs
AbbVie beefs up the immunology pipeline, betting up to $865M on a PhII-ready drug — and fueling a biotech stock frenzy
Endpoints
Thu, 06/18/20 - 10:55 am
Tags:
AbbVie, Mitchell Gold, Dendreon, ALPN-101, immunology, Alpine Immune Sciences, lupus
Dendreon commits to prostate cancer vaccine Provenge with new lease for manufacturing site
Fierce Pharma
Thu, 05/23/19 - 09:59 am
Tags:
Dendreon, prostate cancer, Provenge, drug manufacturing
ASCO: Dendreon touts T-cell response data for prostate cancer vaccine Provenge
Fierce Pharma
Tue, 06/6/17 - 09:55 am
Tags:
ASCO 2017, Dendreon, prostate cancer, Provenge, vaccines
Dendreon eyes real-world data boost for lagging prostate cancer med Provenge
Fierce Pharma
Mon, 05/15/17 - 09:18 am
Tags:
vaccines, Dendreon, prostate cancer, Provenge
Former Dendreon CEO debuts new public company in reverse merger
BioPharma Dive
Wed, 04/19/17 - 04:19 pm
Tags:
Dendreon, reverse merger, Mitchell Gold, Alpine Immune Sciences, Nivalis
Valeant: Why The Dendreon Sale Changes Everything
Seeking Alpha
Tue, 01/17/17 - 09:57 am
Tags:
Valeant Pharmaceuticals, Dendreon
JPM: Valeant sells off Dendreon, skincare brands for $2.1B
BioPharma Dive
Wed, 01/11/17 - 09:58 am
Tags:
Valeant Pharmaceuticals, Dendreon, M&A, JPMHC 2017, Chinese Sanpower Group
In Juno patient deaths, echoes seen of earlier failed company
Stat
Sat, 07/9/16 - 09:16 am
Tags:
Juno Therapeutics, clinical trials, CAR-T, Dendreon
Former Dendreon CEO Secures $48M for Cancer Immunotherapy Startup
Forbes
Mon, 06/13/16 - 10:36 am
Tags:
Mitchell Gold, Dendreon, cancer immunotherapy, Alpine Immune Sciences
Valeant welcomes Dendreon into the fold with a 77-job shearing
Fierce Pharma
Tue, 03/3/15 - 01:25 pm
Tags:
Dendreon, Valeant Pharmaceuticals, layoffs
Can Valeant transform Dendreon's ailing Provenge into a viable cancer competitor?
Fierce Pharma Marketing
Wed, 02/11/15 - 12:04 pm
Tags:
Valeant Pharmaceuticals, Dendreon, Provenge, prostate cancer
Valeant Pharmaceuticals Signs Stalking-Horse Deal With Dendreon Corporation (DNDN)
Bidness Etc.
Fri, 01/30/15 - 08:19 am
Tags:
Valeant Pharmaceuticals, Dendreon, Provenge, M&A
Biotech investor explains why Juno Therapeutics won't be like Dendreon
Bizjournals.com
Fri, 01/2/15 - 07:31 pm
Tags:
Juno Therapeutics, Dendreon
Dendreon heads to February bankruptcy auction without initial bidder
Bizjournals.com
Tue, 12/30/14 - 09:25 pm
Tags:
Dendreon, bankruptcy
Where Are They Now? A Look Back at the Best & Worst Biotech CEOs
TheStreet.com
Tue, 12/16/14 - 12:06 pm
Tags:
biotech, Vertex Pharmaceuticals, Myriad Genetics, Dendreon, Celgene, Regeneron
Dendreon's Alternate Reality
Motley Fool
Thu, 12/4/14 - 10:40 am
Tags:
Dendreon, BFG Pharma, M&A, Provenge, prostate cancer
Don’t expect a Dendreon sale; the troubled biotech will likely end up as a new entity with the current common shares cancelled
Barron's
Wed, 11/12/14 - 11:02 am
Tags:
Dendreon, bankruptcy
Are Expensive Biotech Drugs Bad For Business?
Seeking Alpha
Tue, 11/11/14 - 10:53 am
Tags:
drug pricing, biotech, AbbVie, AstraZeneca, Bristol-Myers Squibb, Dendreon, Gilead Sciences, GSK, Merck, Novartis, Teva Pharmaceutical, Vertex Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.